NX Development Corp is a leading life sciences company based in Lexington, KY, dedicated to revolutionizing the field of brain cancer treatment. Their flagship product, Gleolan, is a groundbreaking imaging agent that assists neurosurgeons in visualizing and removing malignant tissue during surgery, offering unprecedented precision and improving the lives of patients with high-grade gliomas.
Committed to advancing the field of fluorescence guided surgery, NX Development Corp is at the forefront of developing innovative solutions for brain cancer. With FDA approval and market authorization for Gleolan, they are pioneering the future of brain tumor resection by empowering doctors with novel diagnostic options and pushing the boundaries of what their product can achieve, providing hope and a better chance at recovery for brain cancer patients.
Generated from the website